Vertical: CNMBase Year: 2025
Market Size (2025)
$17.56M
Projected (2032)
$27.01M
CAGR (2022–2032)
6.4%
Key Players
10+
Market Overview
The Global 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market was valued at USD 17.556 Million in 2025 and is projected to reach USD 27.014 Million by 2032, registering a CAGR of 6.34% during 2026–2032. Between 2025 and 2032 the market is expected to add USD 9.458 Million in absolute value. Historic data show steady expansion from USD 14.541 Million in 2022 to USD 16.491 Million in 2024, supported by continued demand for trifluoromethylpyridine (TFMP)-based crop protection active ingredients.
2,3-Dichloro-5-(trifluoromethyl)pyridine (CAS 69045-84-7), widely referred to in the industry as 2,3,5-DCTF or DCTF, is a halogenated, fluorinated pyridine intermediate. It is the TFMP building block in highest demand across the agrochemical industry and is the key precursor for the fungicide fluazinam and the aryloxyphenoxypropionate herbicide haloxyfop, as well as for chlorfluazuron, fluopicolide, fluopyram and several newer active ingredients. Market value is therefore closely tied to the production cycles of these downstream actives, most of which are now manufactured in China and India for global supply.
Key Findings
Downstream Product: Others accounted for the largest share at 40.0% (USD 7.022 Million) in 2025. Fluazinam was the largest individually identified product with a 35.0% share and is also the fastest-growing segment, at a CAGR of 7.01% during 2026–2032.
Purity: 98% & Above held the largest share at 80.0% (USD 14.045 Million) in 2025 and is also the fastest-growing grade, at a CAGR of 6.73%.
Region: Asia Pacific led the market with 78.0% of global value (USD 13.694 Million) in 2025, while Middle East & Africa is the fastest-growing region, at a CAGR of 7.84%.
Country: China is the leading country market at USD 7.942 Million in 2025, equal to 45.2% of global value. Saudi Arabia is the fastest-growing country, at a CAGR of 8.41% during 2026–2032.
Segmentation Summary
By downstream product, the market is divided into Fluazinam, Haloxyfop and Others. The Others segment, which includes DCTF consumed in chlorfluazuron, fluopicolide, fluopyram, fluazaindolizine and further TFMP derivatives, generated USD 7.022 Million in 2025. Fluazinam followed at USD 6.145 Million and is expected to reach USD 9.903 Million by 2032, the highest growth rate among the three segments. Haloxyfop accounted for USD 4.389 Million in 2025 and is projected to grow at a CAGR of 5.68%.
By purity, the 98% & Above grade generated USD 14.045 Million in 2025, reflecting the specifications demanded by active ingredient manufacturers for amination and coupling steps. The Below 98% grade accounted for USD 3.511 Million and is projected to grow at a slower CAGR of 4.63%.
Competitive Landscape Summary
The market is moderately consolidated at the merchant manufacturing level and is concentrated in China. Shandong Huimeng Bio-Tech, Inner Mongolia Jiaruimi Fine Chemical and Shandong Fuer are the principal identified dedicated DCTF producers, while Ishihara Sangyo Kaisha (ISK), the pioneer of TFMP chemistry and originator of fluazinam, remains a key technology holder and buyer. Large agrochemical companies such as Bayer, Corteva, Jiangsu Yangnong Chemical, Lier Chemical, Jiangsu Changqing Agrochemical and Zhejiang Yongtai Technology shape demand through captive or contracted consumption of DCTF in downstream actives. Competition centres on cost per kilogram, product purity, environmental compliance and the security of supply. Recent activity includes forward integration by Chinese producers into haloxyfop-P-methyl, fluazinam and fluopyram, and consolidation moves such as Lier Chemical's announced plan to acquire control of Shandong Huimeng.
Challenges and Opportunities
The main challenges are regulatory and environmental. In the European Union, the proposed universal restriction on per- and polyfluoroalkyl substances (PFAS) uses a definition that captures molecules with a fully fluorinated CF3 group, and the approval of fluazinam has been extended to 30 November 2027 while its renewal is pending. DCTF manufacture also involves chlorination and anhydrous hydrogen fluoride, which brings strict safety and emissions requirements in Chinese chemical parks. The agrochemical destocking cycle of 2023–2024 compressed prices for intermediates and actives across the chain.
Opportunities arise from the expiry of key patents on DCTF-derived actives, which is drawing new generic capacity for fluopyram and fluazinam in China, and from the growth of agrochemical manufacturing in India. High-purity grades for new active ingredients, more selective chlorination processes, and rising crop protection demand in Latin America, the Middle East and Africa add further headroom for growth.
Future Outlook
The market is projected to grow from USD 18.686 Million in 2026 to USD 27.014 Million in 2032. Asia Pacific will remain the production and consumption centre, with its value expected to rise to USD 21.311 Million by 2032. Growth will be strongest in Middle East & Africa (7.84%) and Latin America (7.60%), where crop protection demand in soybean, potato and specialty crops is expanding. Fluazinam and high-purity grades will gain share, and producers that combine low-cost integrated manufacturing with strong environmental compliance and long-term supply agreements with active ingredient owners are best positioned for the forecast period.
The 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market market is projected to grow at a CAGR of 6.4% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
2,3-Dichloro-5-(trifluoromethyl)pyridine (CAS No. 69045-84-7; molecular formula C6H2Cl2F3N; molecular weight approximately 216 g/mol) is a pyridine ring substituted with chlorine atoms at the 2- and 3-positions and a trifluoromethyl (CF3) group at the 5-position. It is supplied as a liquid industrial intermediate and is classified under HS heading 2933.39 (heterocyclic compounds with an unfused pyridine ring). The chlorine atom at the 2-position is reactive toward nucleophilic substitution, which allows DCTF to be converted into amines, ethers, nitriles and other derivatives that carry the 3-chloro-5-(trifluoromethyl)pyridin-2-yl group into finished active ingredients.
Commercial DCTF is produced mainly from 3-methylpyridine (3-picoline) or 2-chloro-5-chloromethylpyridine through chlorination to 2,3-dichloro-5-(trichloromethyl)pyridine followed by halogen exchange with hydrogen fluoride, or through vapour-phase chlorination and fluorination processes. A further route involves the selective chlorination of 2-chloro-5-(trifluoromethyl)pyridine.
Included in the scope: merchant and captive DCTF of all purity grades, sold or transferred for the manufacture of fluazinam, haloxyfop (including haloxyfop-P-methyl), and other downstream products such as chlorfluazuron, fluopicolide, fluopyram, fluazaindolizine and pharmaceutical or research derivatives. Market value is measured at the manufacturer's selling price of DCTF.
Excluded from the scope: the value of downstream active ingredients and formulated crop protection products; other TFMP intermediates such as 2-chloro-5-(trifluoromethyl)pyridine (CTF) and 2,3-dichloro-5-(trichloromethyl)pyridine when sold as such; and upstream raw materials including 3-picoline, chlorine and hydrogen fluoride.
Scope of the Study
The study covers the global market for DCTF across the following segmentations, exactly as defined in the market data:
By Downstream Product: Fluazinam, Haloxyfop, Others
By Purity: 98% & Above, Below 98%
By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, with country-level coverage for each region
Historic data are presented for 2022, 2023 and 2024, with 2025 as the base year and forecasts for 2026–2032. Growth rates are expressed as compound annual growth rates (CAGR) for 2026–2032, and all values are expressed in USD Million.
Research Objectives
To estimate the size of the global DCTF market in value terms for 2022–2025 and to forecast it for 2026–2032.
To analyse demand for DCTF by downstream product, with specific attention to fluazinam and haloxyfop production.
To assess the market by purity grade and the shift toward high-purity material for active ingredient synthesis.
To quantify regional and country-level demand, including the concentration of manufacturing in China, India and Japan.
To identify the drivers, restraints, opportunities and trends shaping the market, including PFAS regulation, patent expiries and agrochemical price cycles.
To evaluate the value chain, competitive intensity and regulatory framework affecting DCTF producers and buyers.
To profile the competitive positioning of leading manufacturers and key buyers, and to track strategic developments since 2022.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured process combining secondary research, primary research and analytical modelling. The process began with defining the market and its segmentation, followed by collection of data on DCTF production, downstream active ingredient output, trade flows and pricing. Market estimates were built using both top-down and bottom-up approaches, triangulated, and then validated through discussions with industry participants. Forecasts were developed by applying the impact of identified growth factors to the base-year estimates.
Secondary Research
Secondary research covered sources relevant to fluorinated agrochemical intermediates, including:
Industry associations: CropLife International, the China Crop Protection Industry Association (CCPIA), the China Petroleum and Chemical Industry Federation, the Crop Care Federation of India and the Agro Chem Federation of India.
Government and regulatory bodies: the U.S. Environmental Protection Agency, the European Chemicals Agency, the European Food Safety Authority, China's Ministry of Agriculture and Rural Affairs (ICAMA) and Ministry of Ecology and Environment, India's Central Insecticides Board and Registration Committee, Japan's FAMIC and Brazil's Ministry of Agriculture and Livestock.
Company filings: annual reports, investor presentations, environmental impact assessments and stock exchange announcements of DCTF producers and active ingredient manufacturers.
Technical literature and trade journals: patent databases, the Journal of Pesticide Science, and agrochemical trade publications covering capacity, pricing and registrations.
Trade and paid databases: customs data under HS 2933.39, UN Comtrade, and proprietary chemical and agrochemical databases.
Primary Research
Primary research was conducted to validate secondary findings and to fill data gaps. On the supply side, respondents included production, sales and business development managers at DCTF and TFMP intermediate manufacturers, and procurement and technical staff at active ingredient producers. On the demand side, respondents included sourcing managers at agrochemical formulators, distributors and traders of agrochemical intermediates, and independent industry experts. The objectives were to verify production capacities and utilisation, price levels by purity grade, the allocation of DCTF across downstream products, regional consumption patterns and expected changes in demand over the forecast period.
Market Size Estimation
Top-down approach: the global market was estimated from the output of downstream active ingredients that use DCTF, converted into DCTF requirements using stoichiometric consumption ratios and process yields, and valued at prevailing average selling prices. The global total was then allocated to segments and regions based on production location, consumption and trade patterns.
Bottom-up approach: country-level estimates were built from the production and consumption of DCTF by individual manufacturers and active ingredient producers, adjusted for imports and exports, and aggregated to regional and global totals.
Data triangulation: the results of both approaches were compared with each other and with trade data and industry interviews. Differences were reconciled to produce the final market estimates for each segment, region and country.
Forecasting Methodology
Forecasts were developed by projecting the demand for each downstream product and purity grade in each country, taking into account crop acreage and disease or weed pressure, registration status of the downstream actives, patent expiries and generic entry, new capacity additions, price trends for DCTF and its raw materials, regulatory developments including PFAS-related measures, and macroeconomic conditions in agriculture. Each factor was assessed for its direction and strength of impact over the short, medium and long term, and the results were applied to the 2025 base year.
Base Year, Forecast Period and Currency
Assumptions and Limitations
Exchange rates are assumed to remain stable at average 2025 levels over the forecast period.
No major new restriction on the manufacture or use of DCTF-derived active ingredients is assumed to take effect in the main consuming countries before 2032 beyond those already announced.
Market values are based on average selling prices, which can vary substantially between contract and spot transactions and between purity grades.
A significant share of DCTF is produced and consumed captively within integrated groups; captive volumes are valued at estimated transfer prices.
Several leading producers are privately held and do not publish financial or operating data, which limits the precision of company-level information.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global DCTF market is moderately consolidated at the level of merchant manufacturing and highly concentrated geographically. A small number of Chinese producers with dedicated chlorination and fluorination capacity supply most of the merchant volume, while multinational originators and large Chinese agrochemical groups consume DCTF captively or under long-term contracts in the production of fluazinam, haloxyfop-P-methyl, chlorfluazuron, fluopyram, fluopicolide and other actives. Ishihara Sangyo Kaisha (ISK) of Japan pioneered the industrial chemistry of trifluoromethylpyridines and remains an important technology holder and buyer.
Competition is based mainly on production cost, purity and consistency, environmental and safety compliance, and reliability of supply. Producers compete for long-term supply agreements with originators such as Bayer, ISK, FMC and ADAMA, and with generic active ingredient manufacturers. The market has seen increasing vertical integration, as DCTF producers add downstream active ingredient capacity and agrochemical groups invest upstream, as well as consolidation through acquisitions of producers and process technology holders. Regulatory barriers, including environmental impact assessments and chemical park requirements in China, limit the entry of new producers.
Key Player Positioning
Based on an assessment of their DCTF-related capabilities, scale, integration and strategic activity, the profiled companies are positioned as follows:
Leaders: Shandong Huimeng Bio-Tech, recognised by China's Ministry of Industry and Information Technology as a single-champion manufacturer for DCTF and a supplier to multinational originators; Inner Mongolia Jiaruimi Fine Chemical, an integrated producer of DCTF, related chloropyridines and fluazinam; and Ishihara Sangyo Kaisha, the originator of fluazinam and chlorfluazuron with long-standing TFMP technology.
Challengers: Jiangsu Yangnong Chemical, Lier Chemical, Zhejiang Yongtai Technology and Jiangsu Changqing Agrochemical, large Chinese agrochemical companies that are expanding their presence in DCTF-derived actives through new capacity, acquisitions or integration.
Demand anchors (originators): Bayer and Corteva Agriscience, which own or originated major DCTF-derived actives (fluopyram and fluopicolide; haloxyfop and fluazaindolizine) and influence demand through their sourcing and lifecycle strategies.
Niche players: Shandong Fuer, a smaller producer of DCTF and 2-chloro-5-(trifluoromethyl)pyridine that co-drafted the national group standard for industrial DCTF.
Competitor Dashboard
The competitor dashboard rates each profiled company on four parameters relevant to the DCTF market. Ratings are qualitative assessments on a four-point scale: Low, Medium, High and Very High.
Threat of New Entrants: Medium
Fluorination with anhydrous hydrogen fluoride and high-temperature chlorination require specialised know-how, corrosion-resistant equipment and strict safety systems.
New capacity in China must be located in approved chemical parks and pass environmental impact assessments, which limits the number of feasible sites.
Established agrochemical producers with existing pyridine or fluorine chemistry can enter through backward integration, which keeps the threat from falling to low.
Bargaining Power of Suppliers: Medium
3-picoline and its chlorinated derivatives are produced by a limited number of pyridine manufacturers, giving them some pricing influence.
Chlorine and hydrogen fluoride are widely available in China's chemical clusters, but hydrogen fluoride prices follow fluorspar supply and policy.
Integrated producers that make their own chlorinated pyridines reduce their exposure to supplier power.
Bargaining Power of Buyers: High
Demand is concentrated among a relatively small number of active ingredient producers and multinational originators.
Buyers often use multiple qualified suppliers and long-term contracts with price-adjustment mechanisms.
During destocking periods, buyers can defer orders and press for price reductions.
Threat of Substitutes: Low
DCTF is a structurally required intermediate for fluazinam, haloxyfop and other actives built on the 3-chloro-5-(trifluoromethyl)pyridin-2-yl group; there is no direct chemical substitute.
Substitution occurs mainly at the level of finished actives, where growers can switch to other fungicides or graminicides.
Alternative synthetic routes still pass through DCTF or very close analogues.
Intensity of Competitive Rivalry: High
Several Chinese producers compete on price for the same customer base, and capacity additions can lead to temporary oversupply.
Products are largely standardised by specification, which increases price competition.
Producers differentiate through purity, consistency, integration and reliability of supply.
Threat of New Entrants: Medium; Technical and permitting barriers, offset by integration options for existing chemical producers.
Bargaining Power of Suppliers: Medium; Limited picoline producers; chlorine and hydrogen fluoride widely available.
Bargaining Power of Buyers: High; Concentrated buyer base with multiple qualified suppliers.
Threat of Substitutes: Low; No direct substitute for DCTF in its main downstream syntheses.
Competitive Rivalry: High; Price-based competition among Chinese producers.
Market estimates by geography (2032)
InsightAsia Pacific leads with $21.31M by 2032, while Middle East & Africa is projected to grow fastest at a 8.1% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $0.92M | $1.15M | $1.44M | 4.6% | 5% |
| Europe | $1.23M | $1.52M | $1.89M | 4.4% | 7% |
| Asia Pacific | $11.28M | $15.57M | $21.31M | 6.6% | 79% |
| Latin America | $0.84M | $1.23M | $1.77M | 7.8% | 7% |
| Middle East & Africa | $0.28M | $0.41M | $0.60M | 8.1% | 2% |
| Total | $14.54M | $19.88M | $27.01M | 6.4% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$27.01M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Others | $10.66M | 6.2% | 39% |
| Fluazinam | $9.90M | 7.1% | 37% |
| Haloxyfop | $6.45M | 5.7% | 24% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market covering market dynamics, competitive landscape, and strategic outlook.
The 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market market is projected to reach $27.01M by 2032, growing at 6.4% CAGR. The Others segment holds the largest share.
Demand for DCTF is a derived demand: it moves with the production of the fungicides, herbicides and insecticides that are synthesised from it. The market is therefore influenced by crop prices and acreage, disease and weed pressure, the patent and registration status of downstream actives, and the capacity and cost position of Chinese and Indian manufacturers. Regulatory and environmental factors, particularly in the European Union and in China's chemical parks, act as both constraints and drivers of consolidation.
Market Growth Factor Analysis
Table 2 summarises five macro and five micro factors that shape the market. The impact scores in this table are analyst assessments, rated on a scale of 1 to 10, where a higher score indicates a stronger impact on the market in the stated period.
Growing Use of Trifluoromethylpyridine Chemistry in Crop Protection
Fluorinated active ingredients account for a large and rising proportion of new crop protection molecules, because the trifluoromethyl group improves metabolic stability, lipophilicity and biological activity. Within this group, TFMP-based actives form an important family, and a 2021 review by ISK scientists in the Journal of Pesticide Science identified 2,3,5-DCTF as the TFMP intermediate in highest demand. DCTF is the starting point for fluazinam, haloxyfop and chlorfluazuron, and for the 3-chloro-5-(trifluoromethyl)pyridin-2-yl building block used in fluopicolide, fluopyram and the nematicide fluazaindolizine. Because each of these actives depends on the same intermediate, demand for DCTF benefits from growth across several crop protection categories rather than relying on a single product. Continued research by originators into new pyridine-based fungicides, insecticides and nematicides is expected to keep the TFMP platform relevant and to support new outlets for DCTF over the forecast period.
Fungicide Demand for Late Blight and Clubroot Control
Fluazinam is a broad-spectrum protectant fungicide that uncouples oxidative phosphorylation in fungal cells. It is used mainly to control potato late blight (Phytophthora infestans), including tuber blight, and clubroot in brassicas, as well as Sclerotinia diseases in peanuts, beans and turf. In the United States it has been registered since 1992 for peanuts, potatoes and beans, with turf uses added in 2012, and new tolerances continue to be established, including a multi-crop rule in 2021 and an Asian pear tolerance in 2025. China and India are the world's largest potato producers, and expanding processing potato areas in Asia and Latin America require intensive late blight programmes. The low resistance risk of fluazinam makes it a valued rotation partner against pathogen strains resistant to other fungicide groups. These factors underpin the above-average growth of the Fluazinam segment.
Patent Expiries and Generic Capacity Additions in China
The expiry of patents on DCTF-derived actives is drawing new manufacturers into the market. The core compound patent for fluopyram in China expired in August 2023, and in July 2024 a domestic company other than the originator obtained the first Chinese fluopyram technical registration. Several Chinese producers have since announced or commissioned capacity for DCTF-derived actives, including Hailir's fluopyram project, Inner Mongolia Yongtai's fluopyram project, and Jiangsu Changqing Agrochemical's fluazinam plant, which entered production in 2025. Each new tonne of these actives requires DCTF or its direct derivatives, adding to demand from established fluazinam and haloxyfop production. Generic entry also tends to lower the price of finished actives, which widens their use in price-sensitive markets in Asia, Latin America and Africa, further supporting DCTF consumption.
Grass Weed Control in Broadleaf Crops
Haloxyfop, particularly haloxyfop-P-methyl, is a post-emergence ACCase-inhibitor herbicide (HRAC Group 1) that controls annual and perennial grass weeds in broadleaf crops such as soybean, canola, cotton, pulses, sunflower and vegetables. It is registered in major soybean and oilseed markets, including India, where haloxyfop-R-methyl formulations are registered for soybean, onion, blackgram and cotton, and Australia, among others. The expansion of soybean area in South America and the spread of glyphosate-resistant grass weeds sustain demand for selective graminicides. Chinese manufacturers are adding haloxyfop-P-methyl capacity integrated with their own DCTF production, which secures a stable outlet for the intermediate.
High-Purity Grades for New and Generic Active Ingredients
Newer actives such as fluopyram, fluopicolide and fluazaindolizine, and generic producers seeking registration equivalence, require consistent, high-purity intermediates with tight impurity profiles. The Chinese group standard T/CIESC 46-2023 for industrial DCTF, which took effect in June 2023, sets assay grades of 99.3% and above. Producers able to deliver certified high-purity material with documented impurity profiles can secure long-term supply agreements and premium pricing.
Diversification of Supply to India
Global agrochemical companies are seeking to diversify their supply chains beyond China. India has a large pyridine and picoline base and a growing agrochemical intermediates sector, with new multipurpose plants and long-term contract manufacturing agreements announced since 2024. Domestic DCTF production in India would serve both local active ingredient makers and export customers, and the industry has called for a production-linked incentive scheme covering active ingredients and key intermediates.
Process Innovation and Integration
New process technologies, such as the high-selectivity liquid-phase chlorination of 2-chloro-5-(trifluoromethyl)pyridine patented by Sinochem Lantian and the Zhejiang Research Institute of Chemical Industry, offer higher yields and fewer by-products. Producers that integrate DCTF with upstream picoline chlorination and downstream active ingredient synthesis can lower costs, reduce waste and capture more value along the chain.
PFAS and Environmental Scrutiny of Fluorinated Agrochemicals
The universal PFAS restriction proposed under the EU REACH Regulation defines PFAS as any substance containing at least one fully fluorinated methyl (CF3-) or methylene (-CF2-) carbon atom, a definition that covers DCTF and the actives derived from it. While active substances in plant protection products were proposed for derogation because they are regulated under other EU legislation, the adequacy of this derogation has been questioned during the opinion process of ECHA's scientific committees. Separately, trifluoroacetic acid (TFA), a persistent breakdown product of several CF3-containing pesticides, is under scrutiny: Denmark withdrew products containing six active substances, including fluazinam and fluopyram, in 2025, and ECHA's Committee for Risk Assessment recommended a stricter hazard classification for TFA in June 2026. These developments raise regulatory uncertainty for European demand and for the long-term use of CF3-based actives.
Agrochemical Price Cycle and Margin Pressure
The crop protection industry went through a severe destocking cycle in 2023 and 2024, when high channel inventories and new generic capacity in China led to sharp price declines for many actives and intermediates. Syngenta reported that its 2024 crop protection sales fell 13%, and while volumes recovered in 2025 as inventories normalised, pricing pressure remained, particularly in Brazil and Latin America. Such cycles compress the margins of DCTF producers and can delay capacity investments.
Hazardous Process Chemistry and Safety Regulation
DCTF manufacture involves high-temperature chlorination, chlorine gas and anhydrous hydrogen fluoride, and generates chlorinated by-products and acidic waste streams. Following major chemical accidents in China, provinces such as Jiangsu and Shandong closed or relocated a large number of chemical plants and tightened requirements for chemical parks. Compliance with these safety and environmental standards raises capital and operating costs and limits the number of sites at which new capacity can be approved.
Forward Integration by Intermediate Producers
Chinese DCTF producers are moving downstream into active ingredients. Shandong Huimeng has invested in haloxyfop-P-methyl and fluazifop-P-butyl capacity, while Inner Mongolia Jiaruimi produces fluazinam and has filed for picoxystrobin capacity. This trend increases captive consumption and strengthens the cost position of integrated players.
Industry Consolidation
Consolidation is reshaping the supply base. Haohua Technology completed the acquisition of Sinochem Lantian, a holder of DCTF process patents, in July 2024, and Lier Chemical announced in March 2025 a plan to acquire a controlling stake in Shandong Huimeng. Consolidation is expected to improve pricing discipline and investment capacity among the leading producers.
Regulatory Re-evaluation of Downstream Actives
Fluazinam is under re-evaluation in the European Union, where its approval has been extended to 30 November 2027 pending renewal, and a reassessment of its developmental neurotoxicity data has been requested, with conclusions expected in 2027. Haloxyfop-P is no longer approved in the EU and is not registered in the United States. The outcome of these processes will influence where and how much DCTF-derived product can be sold.
Standardisation and Quality Assurance
The introduction of the T/CIESC 46-2023 standard has created a common quality benchmark for Chinese DCTF. Buyers increasingly expect standardised specifications, batch traceability and environmental, social and governance documentation from intermediate suppliers.
The DCTF value chain extends from basic chemicals to the farmer. Each stage is described below.
Raw materials and inputs: 3-methylpyridine (3-picoline), produced from acetaldehyde, formaldehyde and ammonia, or 2-chloro-5-chloromethylpyridine; chlorine; anhydrous hydrogen fluoride; catalysts; and energy. Raw material availability and the cost of chlorine and hydrogen fluoride strongly affect production costs.
Manufacturing: chlorination of the picoline-based feedstock to 2,3-dichloro-5-(trichloromethyl)pyridine, liquid-phase or vapour-phase fluorination with hydrogen fluoride, neutralisation, and fractional distillation to the required purity. Producers also recover by-products such as 2-chloro-5-(trifluoromethyl)pyridine and treat acidic and chlorinated waste.
Distribution and channels: most volumes are sold under direct, long-term contracts to active ingredient manufacturers and originators. Specialist chemical traders and export agents handle smaller volumes, spot sales and supply to research and pharmaceutical users. Material is shipped as a hazardous good (UN 3082, Class 9) in drums or ISO tanks.
End users: active ingredient manufacturers convert DCTF into fluazinam, haloxyfop-P-methyl, chlorfluazuron, fluopicolide, fluopyram and other actives. These are formulated into crop protection products by agrochemical companies and sold through distributors to growers of potatoes, vegetables, soybean, oilseeds, cotton, fruit and turf.
North America
In the United States, pesticide active ingredients are registered by the Environmental Protection Agency (EPA) under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), and tolerances for residues are set under the Federal Food, Drug, and Cosmetic Act. Fluazinam has been registered since 1992; the EPA published an interim registration review decision in March 2015, with the final decision dependent on endangered species and endocrine assessments. Industrial chemicals such as DCTF fall under the Toxic Substances Control Act (TSCA), and DCTF is listed on the EPA's Chemical Data Reporting system. In Canada, pest control products are regulated by the Pest Management Regulatory Agency under the Pest Control Products Act.
Europe
In the European Union, DCTF as an industrial substance is subject to the REACH Regulation (EC) No 1907/2006 and the CLP Regulation (EC) No 1272/2008; DCTF has active REACH registration dossiers under EC number 410-340-5. Industry self-classifications include acute toxicity, skin sensitisation, serious eye damage and chronic aquatic toxicity. Active substances are approved under Regulation (EC) No 1107/2009: fluazinam's approval has been extended to 30 November 2027 by Implementing Regulation (EU) 2026/372, while haloxyfop-P ceased to be approved at the end of 2020 under Implementing Regulation (EU) 2020/1643. Maximum residue levels are set under Regulation (EC) No 396/2005. The proposed universal PFAS restriction under REACH is a significant pending measure for fluorinated chemicals.
Asia Pacific
In China, pesticide registration is governed by the Regulations on Pesticide Administration and administered by the Institute for the Control of Agrochemicals of the Ministry of Agriculture and Rural Affairs (ICAMA). Revised Pesticide Registration Management Measures took effect on 1 January 2026. New industrial chemical substances are regulated under the Measures for the Environmental Management Registration of New Chemical Substances (MEE Order No. 12). The 14th Five-Year National Pesticide Industry Development Plan, issued in January 2022, promotes consolidation and relocation of pesticide production into chemical parks. In India, pesticides are registered by the Central Insecticides Board and Registration Committee under the Insecticides Act, 1968. In Japan, agricultural chemicals are regulated under the Agricultural Chemicals Regulation Act, with periodic re-evaluation introduced from fiscal year 2021, while industrial chemicals fall under the Chemical Substances Control Law.
Latin America
Brazil's Law No. 14,785/2023 replaced the previous pesticide law of 1989 and restructured the registration process, with applications now filed through the Ministry of Agriculture and Livestock (MAPA) and evaluated together with ANVISA and IBAMA. In Argentina, plant protection products are registered by SENASA, which updated its regulatory framework in 2025 to recognise approvals from reference regulatory authorities and to require GHS-aligned labelling.
Middle East & Africa
In the Middle East and Africa, pesticide registration is handled by national authorities such as South Africa's Department of Agriculture under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act (Act 36 of 1947). The Gulf states regulate pesticide registration at national level, generally referencing international hazard classification and labelling standards.
April 2023: Shandong Huimeng, Inner Mongolia Jiaruimi, Shandong Fuer; Standard; Group standard T/CIESC 46-2023 for industrial 2,3-dichloro-5-(trifluoromethyl)pyridine, co-drafted by the three producers, was published on 27 April 2023 and took effect on 1 June 2023.
April 2023: Jiangsu Yangnong Chemical; Expansion; Announced an investment of about CNY 4.24 billion in its Liaoning Youchuang northern production base for crop protection actives and intermediates.
August 2023: Bayer; Patent expiry; The core compound patent for fluopyram, a DCTF-derived fungicide and nematicide, expired in China, opening the way for generic production.
March 2024: Shandong Huimeng Bio-Tech; Expansion; Launched a project for 3,000 t/y of haloxyfop-P-methyl and 1,500 t/y of fluazifop-P-butyl, together with a technical renovation of its DCTF-series production lines that adds fluorination reactors.
July 2024: Haohua Technology (Sinochem Lantian); Acquisition; Completed the acquisition of 100% of Sinochem Lantian, a fluorochemical company that holds patents for the high-selectivity production of DCTF.
August 2024: Inner Mongolia Jiaruimi Fine Chemical; Expansion; Completed an expansion of its DCTF production capacity at Wuhai, Inner Mongolia.
August 2024: Ishihara Sangyo Kaisha; Strategy; Published its medium-term management plan for FY2024–FY2026, including restructuring of fluazinam sales in Brazil and a target of producing agrochemicals at the lowest cost in the world.
September 2024: Inner Mongolia Jiaruimi Fine Chemical; Expansion; Filed an environmental impact assessment for a 2,000 t/y picoxystrobin project, extending its integration into TFMP-based actives.
September 2024: Zhejiang Yongtai Technology; Expansion; Its subsidiary Inner Mongolia Yongtai filed an environmental impact assessment for 500 t/y of fluopyram together with strobilurin fungicides.
February 2025: Sinochem Lantian / Zhejiang Research Institute of Chemical Industry; Technology; Granted U.S. Patent No. 12,221,415 B2 for a method of preparing DCTF with high selectivity by liquid-phase chlorination.
March 2025: Lier Chemical; Acquisition; Announced a plan to acquire a controlling stake in Shandong Huimeng Bio-Tech, extending its pyridine chain into fluorinated pyridines.
April 2025: Jiangsu Changqing Agrochemical; Expansion; Confirmed that its 500 t/y fluazinam plant had been completed and was in production.
October 2025: Corteva Agriscience; Restructuring; Announced a plan to separate into two companies, with the crop protection business remaining with Corteva; completion targeted for the second half of 2026.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 26 companies operating in the 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market market, including revenue, employee count, and market positioning where available.
Showing 26 of 26 companies
Company Headquarters: Indianapolis, US Founded: 1989 Workforce: ~21,100 Company Working: Corteva Agriscience develops, manufactures, and markets a wide range of products, including seeds and traits, crop protection, software, and digital solutions, seed treatments, forages, inoculants, vegetation management, pasture management, turf and ornamental, urban pest management, and oil. It is directly present in more than 50 countries and covers all major regions such as North America, Asia-Pacific, Latin America, Europe, and the Middle East & Africa. Corteva Agriscience is a subsidiary of Dow Chemical Company. Hence, the provided financial information is of the Dow Chemical Company.
Bayer is a German life-science group with three businesses: Crop Science, Pharmaceuticals and Consumer Health. It is the world's largest combined seed, trait and crop-protection supplier, a mid-sized prescription-drug maker, and a top-five self-care company. Fiscal 2025 sales were EUR 45.6 billion. The 2018 purchase of Monsanto brought leading corn and soybean genetics but also glyphosate and PCB litigation, which has consumed well over EUR 10 billion in settlements and produced net losses in 2023, 2024 and 2025. Under CEO Bill Anderson the company has cut management layers, held the dividend at the legal minimum, and concentrated on four priorities: rebuilding the pharma pipeline, containing litigation, reducing debt and improving crop profitability. In 2026 a 7–2 U.S. Supreme Court ruling on federal pre-emption and a proposed USD 7.25 billion class settlement moved the litigation closer to resolution, though the settlement still awaits final court approval. --- **Company's own description.** Bayer describes itself as a global enterprise with core competencies in the life-science fields of health care and nutrition, operating under the mission "Health for all, Hunger for none" (Annual Report 2025; press boilerplate 2026). Bayer AG is a holding company; operations sit in subsidiaries worldwide. In fiscal 2025 the Group had about 88,000 employees, sales of EUR 45.6 billion and R&D expenses of EUR 5.8 billion. **Independent characterisation.** Bayer is best understood as three distinct businesses sharing a balance sheet, a brand and a legal liability. Crop Science (47 percent of FY2025 sales) is an input supplier to farmers. It earns money from proprietary seed and biotech traits, from chemical and biological crop protection, and to a small extent from digital farming subscriptions. Seed and trait revenue carries royalty-like economics: Bayer licenses traits to other seed companies, and two licensing settlements with Corteva lifted results in Q4 2025 and Q1 2026. The business is strongly seasonal, with Northern Hemisphere sales concentrated in the first half and Latin American sales in the second. Pharmaceuticals (39 percent of sales) discovers, develops and sells prescription medicines, concentrated in cardiovascular and renal disease, oncology, women's health and ophthalmology, plus a radiology unit selling contrast agents and injector hardware. Revenue is almost entirely product sales, with some licence income (for example U.S. Xarelto royalties from Johnson & Johnson, and Eylea outside the United States under a collaboration with Regeneron). The division is in the middle of a patent transition: Xarelto and Eylea are declining while Nubeqa and Kerendia are growing quickly. Consumer Health (13 percent of sales) sells non-prescription brands through pharmacies, mass retail and e-commerce. It is a branded consumer-goods model with stable margins and low capital intensity. **Revenue model mix.** Bayer does not disclose a product/service/licensing split. On the evidence of the Annual Report 2025, the large majority of revenue is product sales; licensing income is embedded in Crop Science seed and trait lines and in Pharmaceuticals; subscription revenue (Climate FieldView, radiology software) is immaterial at Group level. An exact percentage split is not publicly disclosed. **Value-chain position.** Bayer is a research-based originator and manufacturer. It owns discovery, development, active-ingredient and finished-product manufacturing, and commercial organisations, and sells through distributors, retailers, wholesalers, hospitals and pharmacies rather than directly to end users in most markets. **Customers and end markets.** Farmers, agricultural retailers and distributors, and seed licensees (Crop Science); wholesalers, hospitals, physicians, pharmacy chains, governments and payers (Pharmaceuticals); pharmacies, supermarkets, drugstores and online retailers (Consumer Health).
DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).
Nippon Soda is a mid-cap, diversified Japanese chemical group founded in 1920 as a chlor-alkali producer and progressively re-shaped into a portfolio anchored by two high-value franchises: research-based crop protection (Agri Business, 35% of FY3/26 sales) and specialty "Chemical Materials" (25%), complemented by lower-margin but stable trading/logistics, plant engineering and environmental-recycling businesses. Its crown jewels are niche, high-barrier products in which it holds globally relevant positions — the pharmaceutical excipient NISSO HPC (hydroxypropyl cellulose), liquid polybutadiene NISSO-PB for AI-server copper-clad laminates, KrF photoresist polymer VP-POLYMER, and proprietary agrochemicals such as Mospilan (acetamiprid) and Topsin-M. With FY3/26 net sales of JPY 152.1 billion, record net profit of JPY 18.3 billion, an equity ratio of ~66.6%, and a 50%+ total shareholder return policy, the company is a conservatively financed, R&D-led specialty player now pivoting toward healthcare (including animal health) and advanced ICT materials under its Stage III plan to FY3/30. --- ### Company's own description According to its Stage III medium-term plan (May 2026), Nippon Soda describes its mission as creating new value through the power of chemistry, and frames the group as supporting everyday life through chemical products and services across four "material" fields: Agriculture (securing food and sustainable agriculture), Healthcare (healthy life for all people), Environment (toward a resource-recycling society) and ICT (chemical functions for IT devices). The Yuho describes the parent's business as manufacturing, processing and marketing of industrial chemicals, synthetic resins and plastics, dyes, pharmaceuticals, agrochemicals, veterinary pharmaceuticals and other chemical products. ### Business model and revenue model Nippon Soda's revenue is overwhelmingly product-based (manufactured chemical sales), with secondary service revenues from logistics (warehousing, transport, customs brokerage), engineering/EPC contracts and waste treatment. There is no material subscription revenue. Licensing/active-ingredient supply is embedded in Agri Business: the company supplies proprietary active ingredients (AIs) to global majors and sells formulated products through its own overseas network and partners. The revenue mix by nature (approximation from FY3/26 segment data; company does not disclose a product/service split): *Note: the above split is an analytical characterization; the company does not report revenue by nature.* ### Value-chain position **Agri Business:** fully integrated R&D-type agrochemical originator — chemical synthesis, biological/safety research, formulation research, field evaluation, AI manufacturing (including via Nisso Namhae Agro in Korea) and formulation, registration and global marketing (Stage III plan). The company emphasizes that R&D-type agrochemical originators are largely limited to five overseas majors plus Japanese firms, and that Japanese originators punch above their weight in new AI discovery. **Chemical Materials:** upstream chlor-alkali (caustic soda, chlorine, hydrochloric acid) feeding downstream fine/specialty chemistry (living anionic polymerization for NISSO-PB and VP-POLYMER; cellulose derivatization for HPC; penem API synthesis). **Trading & Logistics:** captive and third-party distribution (Nisso Shoji) and specialized hazardous/pharma logistics (Sanwa Soko, Sanso Unyu). **Engineering:** fine-chemical-type EPC (Nisso Engineering) and civil works (Nisso Kensetsu). **Eco Solutions:** waste treatment, zinc recovery from electric-arc-furnace dust, sulfuric acid recycling (Nisso Metallochemical). ### Customer types and end-markets Customers include global agrochemical majors and distributors, farmers' cooperatives (via channels), generic and innovator pharmaceutical companies and supplement makers (HPC, SSF, faropenem API), copper-clad-laminate (CCL) and semiconductor-materials producers (NISSO-PB, 1,2-SBS, VP-POLYMER), thermal-paper manufacturers (color developers), battery-materials producers, industrial users of commodity chemicals, steelmakers (EAF dust treatment), and public/private construction clients (Engineering). End-markets: crop protection (fruit & vegetables first, expanding to grains), pharmaceuticals/nutraceuticals, semiconductors/electronics (AI servers, HBM, automotive chips), infrastructure, and environmental services. ### Independent characterization Nippon Soda is best understood as two engines and three stabilizers. The engines — Agri Business and specialty Chemical Materials — generated roughly 75% of FY3/26 segment operating profit (JPY 11.2 billion of JPY 14.97 billion before adjustments) on 60% of sales. Agri is cyclical and FX-sensitive (65.7% overseas sales ratio in FY3/26), while Chemical Materials has been structurally re-rated from a ~5–6% margin business to ~15–17% after exiting commodity lines (metallic sodium via Alkaline S.A.S., NISSO HI-CHLON, phenol-based color developers, sodium cyanide). The stabilizers (Trading & Logistics, Engineering, Eco Solutions) are low-growth and modest-margin but add scale and cash. A further, often-overlooked profit pillar is equity-method income (JPY 6.06 billion in FY3/26, chiefly Iharabras in Brazil), which made ordinary profit (JPY 22.99 billion) much larger than operating profit and is highly FX-sensitive (BRL/USD).
RPM International is a holding company for more than a dozen semi-autonomous specialty-chemicals franchises. These businesses make coatings, sealants, roofing, concrete admixtures, flooring, fireproofing and building-envelope systems, mostly for maintenance, repair and restoration rather than new construction. Its brand portfolio is unusually deep for a USD 7.9 billion company: Rust-Oleum, DAP, Zinsser, Varathane and The Pink Stuff on the consumer side; Tremco, Euclid, Dryvit, Nudura, Kalzip, Stonhard, Carboline and Fibergrate on the professional side. Each brand holds a leading position in a niche that larger diversified coatings groups do not dominate. Since 2018 RPM has run successive operational-improvement programs (MAP to Growth, MAP 2025, and now "MAP 3.0"). These have lifted gross margin from about 36% (FY2022) to about 41% (FY2026) and moved the group from a loose federation toward a centrally coordinated operating company. RPM is a disciplined, dividend-growing compounder with 52 consecutive annual dividend increases. Its growth vectors are engineered building systems, emerging markets (the "Platform" model) and bolt-on M&A. --- ### Company's own description (FY2026 Form 10-K, Item 1) RPM describes itself as follows: its subsidiaries manufacture, market and sell specialty chemical product lines, including high-quality specialty paints, infrastructure rehab and repair products, protective coatings, roofing systems, sealants and adhesives. These products focus on the maintenance and improvement needs of the construction, industrial, specialty and consumer markets. Footprint as of 31 May 2026: - Products marketed in about 167 countries and territories. - Manufacturing in about 120 locations across 22 countries. - About 31% of sales generated internationally: foreign operations 29.8% of net sales, plus direct U.S. exports of 0.9%. The press-release boilerplate calls RPM "a world leader in specialty coatings, sealants, building materials and related services." ### Business model RPM's model has four defining features. - **Decentralised entrepreneurial structure, becoming more integrated.** The founder's philosophy, still quoted in the 2026 proxy, is: "Hire the best people you can find. Create an atmosphere that will keep them. Then let them do their jobs." Operating companies historically kept their own brands, sales forces and ERP systems. The MAP programs are deliberately centralising procurement, manufacturing, accounting and IT. The stated goal is to consolidate more than 75 ERP systems to one platform per segment (Q4 FY2026 8-K). **Repair and maintenance bias:** Much of the portfolio serves existing assets: roof restoration, re-cover, concrete repair, corrosion control, rust prevention and DIY touch-up. That demand is less cyclical than new-build construction. The FY2026 10-K notes that re-roofing has historically accounted for over three-quarters of U.S. roofing demand. **Systems and turnkey selling:** In CPG and PCG, RPM increasingly sells integrated systems (the "Power of One" building envelope) and supply-and-apply turnkey services. Examples include Stonhard flooring installation and Weatherproofing Technologies roofing services. This captures more of each construction project's spend. **Bolt-on M&A plus organic growth:** RPM completed six acquisitions in each of FY2025 and FY2026 (FY2026 10-K Note F). ### Revenue model mix | Revenue type | Characterisation | Evidence | |---|---|---| | Product sales | Dominant (estimated well above 90% of revenue; exact split not publicly disclosed) | Manufactured coatings, sealants, admixtures and similar products sold through retail, distribution and direct channels | | Installation and services | Material within CPG and PCG; not separately disclosed | WTI/WTC roofing services, turnkey general contracting, TremCare maintenance programs, Stonhard installed flooring, Legend Brands/RoofTec restoration services, Pure Air Control Services | | Warranty and extended programs | Embedded in pricing; generates deferred revenue | Current unearned revenue USD 75.3M and long-term unearned revenue USD 92.4M at FY2026 (standardized balance sheet) | | Licensing and royalties | Minor | The 10-K notes license fees and royalty income from numerous international license agreements, plus equity-method joint ventures | | Subscription | None identified | — | RPM does not disclose a product versus service versus licensing split. From filings, the mix is: ### Value-chain position RPM is a formulator and brand owner, positioned downstream of commodity chemical producers. It buys petroleum-derived resins, solvents, pigments, minerals, metals and packaging (FY2026 10-K, Raw Materials). It is selectively backward-integrated: RPM cites expanding in-house raw material production, and Arnette Polymers makes amine curing agents and epoxy intermediates. Channels downstream include: - Mass merchants and home centres, where the single largest Consumer customer was 20% of Consumer sales in FY2026. - Hardware and paint stores. - Distributors. - Contractors and specifiers. - Direct sales to industrial plant owners, public institutions and infrastructure agencies. ### Customer types and end markets | End market | Segment exposure | Representative brands | |---|---|---| | Commercial / institutional building envelope (roofing, walls, waterproofing, sealants) | CPG | Tremco, Dryvit, Nudura, illbruck, Kalzip, Volteco | | Concrete, cement and infrastructure | CPG, PCG | Euclid, Toxement, Viapol, Prime Resins, Fibrecrete | | Industrial maintenance, oil and gas, petrochemical, power, data centres | PCG | Carboline, Stonhard, Fibergrate, Nullifire | | Food and pharma | PCG | Mantrose-Haeuser, NatureSeal, Profile Food Ingredients | | Marine, wood finishes, powder coatings | PCG | Pettit, Woolsey, FinishWorks/Mohawk, TCI | | Residential DIY and professional painters | Consumer | Rust-Oleum, Zinsser, Varathane, DAP | | Household cleaning | Consumer | The Pink Stuff, Krud Kutter, Mean Green | | Pigments, colorants, OEM and personal care | Consumer (Color Group) | Day-Glo | | Restoration services equipment | CPG (Legend Brands) | Dri-Eaz, Sapphire Scientific | ### Independent characterisation RPM is best understood as a portfolio of niche category leaders with a structural margin-improvement story layered on top. The professional segments (CPG and PCG) are about 66% of sales and supply the growth. In FY2026 they posted record results driven by high-performance buildings, data centres, infrastructure, fireproofing and concrete admixtures. In Q1 FY2027, emerging-market regions grew more than 20%. The Consumer segment is about 34% of sales. It is a cash-generative but volume-challenged DIY business. Organic Consumer sales fell 0.8% in Q4 FY2026 and 4.7% in Q2 FY2026. They recovered to +5.2% in Q1 FY2027 on shelf-space wins and pricing. The equity debate therefore centres on three questions: 1. Can MAP savings and pricing protect margins against renewed raw-material inflation linked to the Middle East conflict? 2. Is the Q1 FY2027 CPG slowdown temporary? 3. Will the 9 November 2026 investor day credibly frame the next margin plan?
Company Headquarters: Amsterdam, Netherlands Founded: 1994 Workforce: ~35,200 Company Working: Akzo Nobel N.V. operates its business by manufacturing products of various industries such as decorative paints, automotive & specialty coatings, industrial coatings, powder coating and marine, protective and yacht coatings. The automotive and specialty coatings segment of the business comprises products such as aerospace coatings, consumer electronics coatings, automotive OEM coatings, vehicle refinishes and sign finishes. Further, its industrial coatings segment offers products including coil and extrusion coatings, wood finishes, packaging coatings, and adhesives. The company owns more than 3,100 patents and has robust research and development capabilities which is evident from the fact that it has spent around USD 1.33 billion on research and development in last five years and possess five R&D centers. The brand portfolio offered by the company includes Dulux, Sikkens, International and Interpon and has a strong geographical presence in around 150 countries.
58 interactive charts drawn from the 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market dataset — market size, each segment breakdown, and every region and country by segment. Open one to read its full data table and download it.
Global 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market By Region
Global 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market By Downstream Product
Global 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market By Purity
Global 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market — North America by Country
Global 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market — North America by Purity
Global 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market — North America by Downstream Product
Global 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market — U.S. by Purity
Global 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market — U.S. by Downstream Product
Global 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market — Canada by Purity
Global 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market — Canada by Downstream Product
Global 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market — Mexico by Purity
Global 2,3-Dichloro-5-(Trifluoromethyl)pyridine Market — Mexico by Downstream Product
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and forecast (2022–2032, USD Million)
Market Size (USD Million)
